Karakteristik Pasien dan Penggunaan Obat Pada Pasien Covid-19 Derajat Sedang Hingga Berat

Abstract

The development of cases of COVID-19 (coronavirus disease 2019) in the province Bali to increase until it ranks 10 th in Indonesia. This study aims to determine the characteristics of patients and the description of drug use for COVID-19 patients at Karangasem Hospital Bali for the period April 2020-Aril 2021. This study used a descriptive observational method with a cross-sectional design through a retrospective data search. The number of respondents as a sample was 200 patients with purposive sampling technique. The data collected is in the form of secondary data, which comes from medical records of COVID-19 patients at Karangasem Hospital. The results of the study showed that the most COVID-19 patients in Karangasem RSUD were from adults as many as 109 people (54.5%). Clinical symptoms experienced by all patients were fever with body temperature 38°C for more than 3 days and headache (100%). Patients who had comorbid as many as 196 people (98%) with pneumonia being the highest comorbid as many as 102 people (51%). The length of hospitalization for patients is generally 0-7 days by 69% (138 people). The highest patient status experienced moderate degree of symptoms by 89% (178 people) and severe 11% (22 people). The most drugs given to patients was vitamin C intravenously by 71% (142 people), while antiviral drugs in the form of oseltamivir (tamiflu) became the least by 1% (2 people). The characteristics of moderate-to-severe COVID-19 patients are dominated by male adult patients, have comorbidities (98%), clinical symptoms experienced by all patients are fever for more than 3 days and headache, with hospitalization for more than 3 days. The type of drug that is most often used is for antipyretic analgesics is paracetamol, the type of antibiotic is azithromycin, the type of antiviral is favipiravir, the type of corticosteroid is dexamethasone.

Determinant analysis of Length of Stay (LoS) in Covid-19 isolation room at RSUD Jend. A. Yani Metro City

“…Hasil penelitian menunjukkan dari 443 sampel penelitian, didapatkan mayoritas pasien COVID-19 terkonfirmasi berusia ≤ 60 tahun (Tabel 1). Berdasarkan penelitian yang telah dilakukan di dunia, usia mayoritas pasien adalah <60 tahun (Maharianingsih et al, 2022). Hal tersebut dapat disebabkan karena kelompok usia produktif mempunyai tingkat mobilisasi lebih sering dibanding usia yang lebih tua (Kraemer et al, 2020).…”

“…(Tabel 1). Maharianingsih et al (2022) dalam penelitiannya menunjukkan hasil yang sama dengan penelitian ini yaitu mayoritas sampel yang dirawat memiliki tingkat keparahan sedang. Hal ini dikarenakan bahwa RS merupakan fasilitas kesehatan rujukan untuk pasien dengan tingkat keparahan sedang-kritis (Burhan, 2020).…”

COVID-19 and Diabetes Mellitus at RSU South Tangerang-Indonesia: Clinical Profile and Treatment Strategies

“…Length of hospitalization is influenced by symptoms of fever that appear and abnormal CT scan values (Wu S et al, 2020) (Baihaqi & Rumaropen, 2022). Treatment is generally 7-14 days (Widjaja et al, 2021), and the recovery rate of patients is higher than those who die (Maharianingsih et al, 2022). The average time for COVID-19 patients to recover is 11 days, but most COVID-19 patients recover between 7-14 days (Dessie et al, 2022).…”

“…Vitamin C in COVID-19 patients is an immunomodulator that can improve immune function and reduce inflammation and oxidative stress (Suryati & Juliadi, 2021). Vitamin C was more often used in COVID-19 patients because a crucial antioxidant component used for critical care; oral and intravenous Vitamin C can reduce the increase in complications, reduce the severity and improve symptoms of COVID-19 patients (Maharianingsih et al, 2022). Methylprednisolone has the most widely used class of corticosteroid drugs (73.2%).…”

“…Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy (Slattery et al, 2014). Acetylcysteine as a mucolytic drug, is most often given to COVID-19 patients because the drug is used to thin phlegm (Maharianingsih et al, 2022) Novorapid contains insulin aspart, rapidly lowering the patient's blood sugar; insulin aspart regulates glucose metabolism, thereby increasing peripheral glucose uptake, especially in skeletal muscle and fat (Evans et al, 2019). ).…”